Crescent Capital holder sells 73K shares at $10.7

Crescent Capital BDC, Inc. (CCAP) had a Form 4 filed by Fidelity & Guaranty Life Insurance Co, a ten percent owner, reporting net open-market sales of 73,457 shares of common stock.

Rhea-AI Filing Summary

Crescent Capital BDC, Inc. (CCAP) had a Form 4 filed by Fidelity & Guaranty Life Insurance Co, a ten percent owner, reporting net open-market sales of 73,457 shares of common stock. The sales on 2026-08-24 and 2026-08-25, executed under a Rule 10b5-1 trading plan, were made at volume-weighted average prices around $10.72–$10.80 per share. A portion of the reported shares is held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the reporting person.

Insider Trade Summary 10b5-1

Net Seller: 73,457 shares

Net Sell 2 txns

Insider FIDELITY & GUARANTY LIFE INSURANCE CO

Role 10% Owner

Sold 73,457 shs ($788K)

Type	Security	Shares	Price	Value
Sale	Common Stock F3, F2	40,000	$10.7398	$430K
Sale	Common Stock F1, F2	33,457	$10.7169	$359K

Holdings After Transaction: Common Stock — 4,131,850 shares (Direct)

Footnotes (3)

1. F1. The shares were sold in multiple transactions at prices ranging from $10.72 to $10.77 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
2. F2. Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.
3. F3. The shares were sold in multiple transactions at prices ranging from $10.74 to $10.80 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold 2026-08-24: 33,457 shares of Common Stock VWAP price 2026-08-24: $10.7169 per share Shares sold 2026-08-25: 40,000 shares of Common Stock +2 more

5 metrics

Shares sold 2026-08-24 33,457 shares of Common Stock Open-market sale by ten percent owner

VWAP price 2026-08-24 $10.7169 per share Volume weighted average sale price, trades from $10.72 to $10.77

Shares sold 2026-08-25 40,000 shares of Common Stock Open-market sale by ten percent owner

VWAP price 2026-08-25 $10.7398 per share Volume weighted average sale price, trades from $10.74 to $10.80

Total shares sold 73,457 shares of Common Stock Net shares sold across both reported transactions

Key Terms

Rule 10b5-1 trading plan, volume weighted average price, ten percent owner

3 terms

Rule 10b5-1 trading plan regulatory

"The transactions were executed under a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

volume weighted average price financial

"The price reported reflects the volume weighted average price"

The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.

ten percent owner regulatory

"the reporting person is identified as a ten percent owner"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did CCAP report in this Form 4?

The Form 4 reports that Fidelity & Guaranty Life Insurance Co sold a total of 73,457 CCAP common shares in two open-market transactions on 2026-08-24 and 2026-08-25.

What prices were the CCAP shares sold for in this filing?

On 2026-08-24, 33,457 shares were sold at a volume weighted average price of $10.7169, with actual prices ranging from $10.72 to $10.77. On 2026-08-25, 40,000 shares were sold at $10.7398, within a $10.74 to $10.80 range.

Was the CCAP insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing indicates that the reported transactions were made under a Rule 10b5-1 trading plan, meaning the sales followed a pre-arranged trading schedule.

Who is the reporting person in this CCAP Form 4 and what is their status?

The reporting person is Fidelity & Guaranty Life Insurance Co, identified as a ten percent owner of Crescent Capital BDC, Inc.

How are the CCAP shares held according to the Form 4 footnotes?

The Form 4 states that the reported shares of CCAP common stock are held by Fidelity & Guaranty Life Insurance Company of New York, which is a wholly owned subsidiary of the reporting person.

How many CCAP shares were sold on each transaction date?

The reporting person sold 33,457 shares of CCAP common stock on 2026-08-24 and 40,000 shares on 2026-08-25, for a combined total of 73,457 shares sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/26/2026 - 03:27 PM EDT Accepted by SEC EDGAR 08/26/2026 - 03:27 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FIDELITY & GUARANTY LIFE INSURANCE CO

(Last) (First) (Middle)

801 GRAND AVENUE, SUITE 2600

(Street)

DES MOINES IOWA 50309

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Crescent Capital BDC, Inc. [ CCAP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/24/2026		S		33,457	D	$10.7169(1)	4,171,850(2)	D
Common Stock	08/25/2026		S		40,000	D	$10.7398(3)	4,131,850(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold in multiple transactions at prices ranging from $10.72 to $10.77 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

2. Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

3. The shares were sold in multiple transactions at prices ranging from $10.74 to $10.80 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

	Tessa Cantonwine, Secretary	08/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)